Mary E. Duffy

728 total citations
8 papers, 486 citations indexed

About

Mary E. Duffy is a scholar working on Surgery, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Mary E. Duffy has authored 8 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Molecular Biology. Recurrent topics in Mary E. Duffy's work include Coronary Interventions and Diagnostics (4 papers), Cardiac Imaging and Diagnostics (4 papers) and Acute Myocardial Infarction Research (2 papers). Mary E. Duffy is often cited by papers focused on Coronary Interventions and Diagnostics (4 papers), Cardiac Imaging and Diagnostics (4 papers) and Acute Myocardial Infarction Research (2 papers). Mary E. Duffy collaborates with scholars based in United States and Canada. Mary E. Duffy's co-authors include Sanjeev Sharma, Annapoorna Kini, Jonathan D. Marmur, Paul C. Lee, Michael C. Kim, Ajay Agarwal, Arvin C. Dar, William M. Marsiglia, Arthur Chow and Y. Jayasudhan Reddy and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of the American College of Cardiology.

In The Last Decade

Mary E. Duffy

8 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary E. Duffy United States 7 198 152 141 110 59 8 486
Nieves Tarín Spain 15 146 0.7× 198 1.3× 125 0.9× 27 0.2× 22 0.4× 37 508
Hector Garcia-Garcia Netherlands 10 185 0.9× 204 1.3× 280 2.0× 171 1.6× 98 1.7× 16 619
Maysoon Elkhawad United Kingdom 8 128 0.6× 126 0.8× 89 0.6× 66 0.6× 125 2.1× 13 436
Patrick Hu United States 11 247 1.2× 209 1.4× 216 1.5× 118 1.1× 78 1.3× 30 672
Vijay M. Varma United States 15 186 0.9× 93 0.6× 122 0.9× 241 2.2× 93 1.6× 24 705
Brad Hirakawa United States 10 318 1.6× 96 0.6× 31 0.2× 25 0.2× 60 1.0× 18 566
Joseph Pierre Aboumsallem Netherlands 15 135 0.7× 336 2.2× 80 0.6× 63 0.6× 49 0.8× 36 570
You Zhou China 12 315 1.6× 175 1.2× 129 0.9× 62 0.6× 61 1.0× 42 653

Countries citing papers authored by Mary E. Duffy

Since Specialization
Citations

This map shows the geographic impact of Mary E. Duffy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E. Duffy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E. Duffy more than expected).

Fields of papers citing papers by Mary E. Duffy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary E. Duffy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E. Duffy. The network helps show where Mary E. Duffy may publish in the future.

Co-authorship network of co-authors of Mary E. Duffy

This figure shows the co-authorship network connecting the top 25 collaborators of Mary E. Duffy. A scholar is included among the top collaborators of Mary E. Duffy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary E. Duffy. Mary E. Duffy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Marsiglia, William M., et al.. (2020). Structural basis for the action of the drug trametinib at KSR-bound MEK. Nature. 588(7838). 509–514. 111 indexed citations
2.
Yu, Jia Xin, Amanda J. Craig, Mary E. Duffy, et al.. (2019). Phenotype-Based Screens with Conformation-Specific Inhibitors Reveal p38 Gamma and Delta as Targets for HCC Polypharmacology. Molecular Cancer Therapeutics. 18(9). 1506–1519. 17 indexed citations
3.
Clarke, Daniel, Maxim V. Kuleshov, Brian M. Schilder, et al.. (2018). eXpression2Kinases (X2K) Web: linking expression signatures to upstream cell signaling networks. Nucleic Acids Research. 46(W1). W171–W179. 133 indexed citations
4.
Kini, Annapoorna, Paul Lee, Ajay Agarwal, et al.. (2005). Intracoronary brachytherapy for in-stent restenosis using long sources reduces restenosis.. PubMed. 17(6). 302–6. 1 indexed citations
5.
Kini, Annapoorna, Paul C. Lee, Jonathan D. Marmur, et al.. (2003). Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality. The American Journal of Cardiology. 93(1). 18–23. 139 indexed citations
6.
Kini, Annapoorna, Paul C. Lee, Michael C. Kim, et al.. (2003). Prediction of outcome after percutaneous coronary intervention for the acute coronary syndrome. The American Journal of Medicine. 115(9). 708–714. 9 indexed citations
7.
Kini, Annapoorna, Mazullah Kamran, Javed Suleman, et al.. (2002). Changing trends in incidence and predictors of radiographic contrast nephropathy after percutaneous coronary intervention with use of fenoldopam. The American Journal of Cardiology. 89(8). 999–1002. 55 indexed citations
8.
Kini, Annapoorna, et al.. (2002). Postprocedure chest pain after coronary stenting: implications on clinical restenosis. Journal of the American College of Cardiology. 41(1). 33–38. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026